Literature DB >> 30878799

Future of cancer incidence in Shanghai, China: Predicting the burden upon the ageing population.

Zhenqiu Liu1, Yanfeng Jiang2, Qiwen Fang3, Huangbo Yuan3, Ning Cai1, Chen Suo1, Weimin Ye4, Xingdong Chen5, Tiejun Zhang6.   

Abstract

AIM: The age-specific cancer patterns have changed significantly over the last few decades in urban Shanghai. Predicting the cancer incidence in an ageing population can help to anticipate future resource needs, evaluate primary prevention strategies, and inform further research studies.
MATERIALS AND METHODS: Annual cancer cases and population data from 1988 to 2013 were collected from Shanghai Cancer Registry. A Bayesian age-period-cohort model was applied to project the future cancer incidence with demographical changes from 2014 to 2025.
RESULTS: From 1988 through 2013, the urban population aged < 65 years decreased by 19.5%, while the population aged ≥ 65 years increased by 58.4%. In the same period, cancer cases increased by 66.0% (from 8315 to 13,806) and 88.6% (from 7448 to 14,048) in these two populations, respectively. From 2014-2025, the population size is expected to decrease by an additional 29.6% in people aged < 65 years, while it will increase by an additional 68.3% in people aged ≥ 65 years. Correspondingly, the model predicts an 87.5% and 143.4% increase in cancer cases for these two populations, respectively. The most pronounced increase was found in thyroid cancer in both sexes, followed by prostate, kidney, and colon cancer in men. In women, lung, kidney, and cervical cancer in women was expected to increase.
CONCLUSIONS: The number of cancer cases in urban Shanghai, especially in older people, is expected to significantly increase in the next decade. Particular strategies targeting the elderly are required to combat the cancers.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ageing population; Cancer incidence; Projections; Shanghai

Mesh:

Year:  2019        PMID: 30878799     DOI: 10.1016/j.canep.2019.03.004

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  10 in total

1.  Changing incidence and projections of thyroid cancer in mainland China, 1983-2032: evidence from Cancer Incidence in Five Continents.

Authors:  Mandi Li; Jiao Pei; Minghan Xu; Ting Shu; Chengjie Qin; Meijing Hu; Yawei Zhang; Min Jiang; Cairong Zhu
Journal:  Cancer Causes Control       Date:  2021-06-21       Impact factor: 2.506

2.  Trends and projections of kidney cancer incidence at the global and national levels, 1990-2030: a Bayesian age-period-cohort modeling study.

Authors:  Zhebin Du; Wei Chen; Qier Xia; Oumin Shi; Qi Chen
Journal:  Biomark Res       Date:  2020-05-13

3.  BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.

Authors:  Cong Zhang; Chunrui Bo; Lunhua Guo; Pingyang Yu; Susheng Miao; Xin Gu
Journal:  World J Surg Oncol       Date:  2019-12-16       Impact factor: 2.754

4.  Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study.

Authors:  Yang Ou; Yichen Long; Lili Ji; Yanxia Zhan; Tiankui Qiao; Xiangdong Wang; Hao Chen; Yunfeng Cheng
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

5.  Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer.

Authors:  Sahyun Pak; Kyu-Won Jung; Eun-Hye Park; Young Hwii Ko; Young-Joo Won; Jae Young Joung
Journal:  Investig Clin Urol       Date:  2022-03

6.  Correlation between periodontitis and prostate-specific antigen levels in the elderly Chinese male population.

Authors:  Mengyun Mao; Haihua Zhu; Yanyi Xie; Da Ni; Fudong Zhu; Qianming Chen
Journal:  BMC Oral Health       Date:  2022-05-06       Impact factor: 3.747

7.  The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway.

Authors:  Zhen-Xing Yu; Cheng Xiang; Sheng-Gui Xu; Yang-Ping Zhang
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

8.  MRI radiomics predicts progression-free survival in prostate cancer.

Authors:  Yushan Jia; Shuai Quan; Jialiang Ren; Hui Wu; Aishi Liu; Yang Gao; Fene Hao; Zhenxing Yang; Tong Zhang; He Hu
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 9.  Epidemiology and genomics of prostate cancer in Asian men.

Authors:  Yao Zhu; Miao Mo; Yu Wei; Junlong Wu; Jian Pan; Stephen J Freedland; Ying Zheng; Dingwei Ye
Journal:  Nat Rev Urol       Date:  2021-03-10       Impact factor: 14.432

10.  Prediction of cancer survival for cohorts of patients most recently diagnosed using multi-model inference.

Authors:  Camille Maringe; Aurélien Belot; Bernard Rachet
Journal:  Stat Methods Med Res       Date:  2020-12       Impact factor: 3.021

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.